Fresenius SE & Co. KGaA
Home
|
Contacts
|
Imprint
|
Sitemap
|
Glossary
|
RSS
|
German
Who we are
The Health Care Group
Products and Services
Facts and Figures
Locations Worldwide
Management Board
Supervisory Board
Corporate Governance
Business Development / M&A
Environment
History
Frequently Asked Questions
Investor Relations
Fresenius Share/ADR
Credit Relations
News
Publications
Presentations
Directors' Dealings
Outlook, Facts and Figures
Annual General Meeting
Financial Calendar and Conferences
Information & Order Service
Frequently Asked Questions
Contacts
Stock Dictionary
Press
Press Releases
Photo Service
Audio / Video Service
TV Service
Calendar
Facts and Figures
Contacts
Press Kit 100 Years
Health Care
Fresenius Medical Care
Dialysis at a Clinic or at Home
Hemodialysis
Peritoneal Dialysis
Supplemental Drugs
Other Extracorporeal Systems
Fresenius Kabi
Infusion Therapy
Clinical Nutrition
Home Care
Fresenius Helios
Care Structure
Medical Quality
Knowledge Management
HELIOS Highlights
Fresenius Vamed
Fresenius Biotech
Transplantation
Cancer Therapy
All Segments
Calendar
Links
Contacts
Career
SEARCH
Press Releases
All
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
Business & Finance
Quarterly Results
Medicine & Research
Order Service
Photo Service
Audio / Video Service
TV Service
Calendar
Facts and Figures
Contacts
Press Kit 100 Years
Share Price
Next Event
17.05.2013
Annual General Meeting
>>>
Further events
>>>
All - 2003
10.12.2003
2003 Dialyzer Production reaches Milestone of 50 Million Dialyzers
Text as PDF file
04.11.2003
Fresenius announces results of first nine months 2003
Text as PDF file
04.11.2003
Fresenius Medical Care AG reports Third Quarter and Nine Months Results 2003
Text as PDF file
29.10.2003
Fresenius Medical Care AG Comments on Sale of Preference Shares by Investor Group
Text as PDF file
23.09.2003
Phase I/II study completed successfully: New antibody to treat ovarian cancer patients with symptomatic ascites (fluid accumulation in the abdominal cavity) shown to be well tolerated
Text as PDF file
04.09.2003
Fresenius Medical Care announces appointment of new Chief Financial Officer
Text as PDF file
05.08.2003
Fresenius announces half year results 2003
Text as PDF file
05.08.2003
Fresenius Medical Care AG reports Second Quarter and Six Months Results 2003
Text as PDF file
17.06.2003
Fresenius grants licence to market immunosuppressive agent ATG in North America
Text as PDF file
05.06.2003
Dr. Krick new Chairman of the Supervisory Board of Fresenius AG
Text as PDF file
07.05.2003
Fresenius Medical Care reports First Quarter 2003 results
Text as PDF file
07.05.2003
Fresenius announces 1st Quarter-Results 2003
Text as PDF file
14.04.2003
Fresenius Medical Care AG Announces Settlement of Merger-Related Commercial Payer Litigation
Text as PDF file
04.04.2003
Fresenius employees donate more than 30,000 euros for medical aid projects worldwide
Text as PDF file
12.03.2003
Dicamed AB acquired by Fresenius Medical Care AG
Text as PDF file
07.03.2003
Fresenius Medical Care announces Change in Board of Management
Text as PDF file
07.03.2003
Fresenius announces change in chairmanship of Managing Board
Text as PDF file
25.02.2003
Fresenius Medical Care reports Fourth Quarter and Full-Year 2002 results
Text as PDF file
25.02.2003
Fresenius announces results of Financial Year 2002
Text as PDF file
12.02.2003
Fresenius Medical Care announces definitive agreement to settle fraudulent conveyance and all other W.R. Grace bankruptcy related issues
Text as PDF file
04.02.2003
Fresenius Medical Care announces exercise of Class D preferred stock redemption rights
Text as PDF file
Home
>
Press
>
Press Releases
>
All
>
2003
